Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Benjamin Haaland, Akhil Chopra, Sanchalika Acharyya, André P. Fay, Gilberto de Lima Lopes

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences